Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Global X Genomics & Biotechnology ETF - USD (GNOM) and WisdomTree BioRevolution Fund (WDNA) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Health Care. GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.45% for WDNA. GNOM is down -0.99% year-to-date (YTD) with -$2M in YTD flows. WDNA performs better with 4.96% YTD performance, and -$357K in YTD flows. Run a side-by-side ETF comparison of GNOM and WDNA below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM WDNA | -2.35%-0.46% | -3.29%+4.60% | -0.99%+4.96% | +29.80%+38.09% | -6.02%+12.49% | -51.80%n/a |
| Flows | GNOM WDNA | --$357K | -$4M-$357K | -$2M-$357K | -$19M-$357K | -$115M-$524K | +$11M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM WDNA | +23.45%+22.81% | +30.08%+28.57% | +28.53%+24.57% | +33.47%n/a |
| Max drawdown | GNOM WDNA | -10.89%-8.60% | -22.14%-17.47% | -46.50%-37.80% | -72.17%n/a |
| Max drawdown duration | GNOM WDNA | 48d48d | 113d106d | 1031d901d | 1714dn/a |
GNOM | WDNA | |
Last sale 3/11/2026 at 1:30 PM | $45.00 | $17.67 |
| Previous close 03/11/2026 | $45.33 | $17.74 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
GNOM | WDNA | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
GNOM | WDNA | |
|---|---|---|
| Last price | $45.00 | $17.67 |
| 1D performance | -0.74% | -0.39% |
| AuM | $49.36 M | $2.31 M |
| E/R | 0.5% | 0.45% |
GNOM | WDNA | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Global X | WisdomTree |
| Benchmark | Solactive Genomics Index | WisdomTree BioRevolution Index |
| N° of holdings | 46 | 75 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 5, 2019 | June 3, 2021 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
